As is well known, the European Patent Office (EPO) uses the
problem solution test to evaluate inventive step. The test has 3 steps:
- determining the closest prior art
- establishing the objective technical problem to be solved
- considering whether the claimed invention, starting from
the closest prior art and the objective technical problem would have been
obvious to the skilled person.
The test has more subtleties than one would imagine. Here are our observations:
1. What is the Correct Technical Problem?
Choosing the correct technical problem is sometimes crucial
to convincing an Examiner that the claims have inventive step. Ensure that that
all of the technical advantages are represented in the problem as best as
possible. For example where the
invention is a new gene the problem could be stated:
a) providing a novel gene
b) providing a gene that encodes a protein with X activity
c) providing a gene encoding a protein with X activity, the
modulation of which can be used to treat condition Z
Clearly it will be easier to show that the prior art does
not suggest (c) versus showing it does not suggest (a). In general narrowly defined problems are
advantageous in examination.
2. What is the Correct Closest Prior Art?
Ensure that the correct closest prior art is chosen, because
that will define the problem. Hindsight
based on the invention can lead to an incorrect choice of closest prior art,
and if that happens it should be pointed out to the Examiner. In particular it should be borne in mind that
the search is performed using knowledge of the invention. Again if it is felt that the cited documents
would not have been identified by the skilled person without hindsight then
this should be used in inventive step arguments.
3. Is Recognition of the Problem Part of the Contribution?
Do not assume that the objective technical problem would
have been recognised by the skilled person when looking at the closest prior
art. For example if the invention
concerns minimising the side effects of a drug, unless the side effects are
recognised the prior art, then identifying the side effects themselves is part
of the contribution made by the invention, and that must be appreciated when
inventive step is evaluated.
4. Should the
Application Refer to the Problem Which is Solved?
When drafting an application is not always clear as to
whether one should define the problem being solved. This is seen by some as a sort of admission which
could disadvantage them if the prior art situation changed. We believe a lot of caution is needed when
drafting, and it is better to define ‘contributions’ made by the invention
which reflect the different advantages.
Broad and narrow contributions can be defined which will assist with
defining a problem during examination, but these should be written bearing in
mind that the problem often changes as new prior art is identified in the
search.
5. Should the Claims
Refer to the Technical Effect When it is Not a Limiting Feature?
This is a more subtle point than it would first appear. The technical effect allows the problem to be
solved, and so it must be fully appreciated when evaluating inventive
step. The following claims can have the
same scope:
a) Compound X with formula Y
b) An inhibitor of crystallisation X, with formula Y
However the contribution is much more apparent from the way
(b) is written. Given that success in
examination can often be determined by how much the Examiner appreciates the
technical effect, including the technical effect within the claims can be
advantageous.
6. The Application Needs to Show That the Problem has been
Solved
When drafting, thought should be given to which problems
have been shown to be solved by the
available data, and whether there is a risk that an Examiner will consider the
problem not to have solved. This can
happen in the situation where a compound is alleged to have therapeutic
activity based on in vitro data. Alternative problems should be considered,
and basis should be provided for limiting to those problems. In the case of a vaccine an Examiner may
object that ‘protection’ against the condition has not been demonstrated, but
may accept a claim which refers to ‘stimulating an immune response’ without requiring
protection to be achieved. The
application should provide the flexibility to see the technical effect in
different ways, allowing the problem and the invention to be defined in
different ways.
7. The Plausibility
Test
The EPO may use the plausibility test when there is doubt
about whether the technical problem has been solved. It evaluates whether it is ‘plausible’ that
the problem has been solved based on the
content of the application, and so the Examiner may exclude additional data
or documents from the analysis. That
means that when one is drafting in a situation where there may not be enough data
one must take care to explain within the application how the data shows the
problem has been solved.
8. Don’t Undersell the Problem which has been Solved
When drafting the application, one must not be too critical
of the contribution that has been made.
A reasonable level of extrapolation can be done based on the technical
effect which has been achieved. If a compound
has been found to reduce viral growth, then it is reasonable to claim the
compound for use in treating conditions caused by the virus, and perhaps also
conditions caused by related viruses.
One must not allow an over-critical approach to impact the drafting in a
way that makes the invention look less impressive.
9. Choice of the Technical Problem in Opposition
Bear in mind when attacking a patent in opposition it is
generally advantageous to define the problem more broadly. A problem could be defined in the following
two ways:
a) providing a new gene
b) providing a new gene which is the basis of pancreatic
cancer
Problem (a) looks less impressive, and this more broadly
defined problem could allow more prior art documents to become relevant to
inventive step, and make it easier to show that the invention can be derived from
the prior art. When looking to define
the problem the data in the patent under attack should be looked at in a very
critical way.
10. Different Problems May be Solved for Different Claims
Bear in mind that the problem solved by the first claim may
dominate the evaluation of inventive step.
Therefore thought should be given as to how the claims should be ordered
to best present the invention.
You may also wish to see related articles Patent Advice for Tech Transfer Offices and When is a device not a device, T2003 of 08
You may also wish to see related articles Patent Advice for Tech Transfer Offices and When is a device not a device, T2003 of 08
No comments:
Post a Comment